ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657174 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657174; 2) Community: the network communities that were significantly associated with the response to NSC 657174; 3) Molecule: the relationships between components within communities and NSC 657174; 4) MDR: the compounds that were significantly associated with the NSC 657174.

NSC Compound Enrichment Correlation
NSC 163062 TRIPTOLIDE 0.0392716453377535 0.19607332
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0392716453377535 -0.16302163
NSC 228178 Palladate(1-), .mu.-chlorodichloro[.mu.-[2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamidato]](2-)]di-, hydrogen 0.0392716453377535 -0.061308455
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0392716453377535 0.23262605
NSC 286193 Tiazofurin (USAN) 0.0392716453377535 -0.10120652
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0392716453377535 0.10318343
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0392716453377535 0.23824378
NSC 48300 ANTINEOPLASTIC-48300 0.0392716453377535 0.31783382
NSC 529108 4-Fluoro-D,L-tryptophan 0.0392716453377535 0.016533694
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0392716453377535 0.10798731
Total:85  Current:66    [First] [Prev] [Next] [Last]